The side effect and adverse event issues are real, they are important, they need to be addressed in the long run as we get even more potent immunotherapies, but they should not be perceived at the moment as reasons to not take immunotherapeutics because the drugs themselves have such a positive impact on cancers in certain settings.
Phase 2, Proliferation (Days 5-21): BPC-157 drives fibroblast proliferation and collagen synthesis
Effects of treatment for psoriasis on circulating levels of leptin, adiponectin and resistin: a systematic review and meta-analysis
The systemic nature of these peptide mechanisms means they could potentially address both skin and joint manifestations of psoriatic disease
Who Is Typically a Good Candidate for GLOW
Some products out there make vague anti-inflammatory promises, but the best, most effective first step is to identify what habits or behaviors could potentially be driving low-grade, persistent inflammation